Precision Medicine

UROMONITOR - A reliable, non-invasive solution (performed on a urine sample) validated for the active surveillance of patients with non-muscle-invasive bladder cancer, as well as in the context of initial diagnosis, regardless of the tumor’s stage and grade.

Pancreatic cancer is a malignant tumor that affects the pancreas. Among tumors affecting the digestive and endocrine systems, it has the worst prognosis.

Pancreatic cancer results from an abnormality in the process of cell regeneration in the tissues that make up the pancreas. In Portugal, there are 1,000 new cases of pancreatic cancer each year.

The Germano de Sousa Center for Laboratory Medicine currently offers liquid biopsy for the analysis of solid tumors.

The MyPharmaGenes® PGx test provides useful information for developing a personalized treatment plan for conditions in the fields of psychiatry, pain management, oncology, diabetes, and cardiovascular disease.
The MyPharmaGenes® PGx test uses iPLEX MassArray technology (99% accuracy and sensitivity).

Laboratory diagnosis of HPV (human papillomavirus) is one of the centers of excellence at the Germano de Sousa Center for Laboratory Medicine...

A new solution to help you develop personalized health and wellness strategies based on your genetic and biochemical profile

The human papillomavirus (HPV) is a virus that infects keratinocytes in the skin or mucous membranes and has more than 200 different serotypes. Most subtypes are associated with benign lesions, but certain types are frequently found in specific neoplasms.